In vivo MR angiographic quantification of axial and twisting deformations of the superficial femoral artery resulting from maximum hip and knee flexion

Journal of Vascular and Interventional Radiology

Volumn 17, Issue 6, 2006, Pages 979-987

  Cheng, Christopher P ^a,c   Wilson, Nathan M ^b   Hallett, Richard L ^b   Herfkens, Robert J ^b   Taylor, Charles A ^a,b  

^a Stanford University   (United States)

^b STANFORD UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY POSITION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HIP; HUMAN; KNEE FUNCTION; LEG BLOOD VESSEL; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SUPERFICIAL FEMORAL ARTERY; SUPINE POSITION;

ADULT; CONTRAST MEDIA; FEMALE; FEMORAL ARTERY; HIP JOINT; HUMANS; KNEE JOINT; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MOVEMENT; SUPINE POSITION;

EID: 33748146391     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000220367.62137.e8     Document Type: Article

References (17)

1. Capek P, McLean GK, Berkowitz HD. Femoropopliteal angioplasty: factors influencing long-term success. Circulation 1991; 83:I70-I80.
2. Henry M, Amor M, Ethevenot G, et al. Palmaz stent placement in iliac and femoropopliteal arteries: primary and secondary patency in 310 patients with 2-4 year follow-up. Radiology 1995; 197:167-174.
3. Gray BH, Sullivan TM, Childs M, et al. High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty. J Vasc Surg 1997; 25:74-83.
4. Duda SH, Pusich B, Richter G, et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six month results. Circulation 2002; 106:1505-1509.
5. Allie DE, Hebert CJ, Walker CM. Nitinol stent fractures in the SFA. Endovasc Today 2004:22-34.
6. Scheinert D, Scheinert S, Sax J, et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 2005; 45:312-315.
7. Drisko K. Characterizing the unique dynamics of the SFA: the RESIStent program. Endovasc Today 2004(suppl):6-8.
8. Carpenter JP, Anderson WN, Brewster DC, et al. Multicenter pivotal trial results of the Lifepath system for endovascular aortic aneurysm repair. J Vasc Surg 2004; 39:34-43.
9. Sacks BA, Miller A, Gottlieb M. Fracture of an iliac artery Palmaz stent. J Vasc Interv Radiol 1996; 7:53-55.
10. Babalik E, Gulbaran M, Gurmen T, et al. Fracture of popliteal artery stents. Circ J 2003; 67:643-645.
11. Phipp LH, Scott DJ, Kessel D, et al. Subclavian stents and stent-grafts: cause for concern? J Endovasc Surg 1999; 6:223-226.
12. Knirsch W, Haas NA, Lewin MA, et al. Longitudinal stent fracture 11 months after implantation in the left pulmonary artery and successful management by a stent-in-stent maneuver. Catheter Cardiovasc Interv 2003; 58:116-118.
13. Baguet JP, Thony F, Sessa C, et al. Stenting of a renal artery compressed by the diaphragm. J Hum Hypertens 2003; 17:213-214.
14. Sianos G, Hofma S, Serruys PW. Stent fracture and restenosis in the drug-eluting stent era. Cathet Cardiovasc Intervent 2004; 61:111-116.
15. Smouse HB, Nikanorov A, LaFlash D. Changes in major peripheral arteries during joint movement before and after stent placement in the cadaver model. In: Program and Abstracts from Transcatheter Cardiovascular Therapeutics, Sept 27-Oct 4, 2004; Washington, DC. page TCT-58.
16. Draney MT, Alley MT, Tang BT, et al. Importance of 3D nonlinear gradient corrections for quantitative analysis of 3D MR angiographic data. Presented at: International Society for Magnetic Resonance in Medicine Conference, May 18-24, 2002, Honolulu, Hawaii.
17. Wilson NM, Wang KC, Dutton RW, et al. A software framework for creating patient specific geometric models from medical imaging data for simulation based medical planning of vascular surgery. Lecture Notes Comp Sci 2001; 2208:449-456.